John M. Holliman, III
2018
In 2018, John M. Holliman, III earned a total compensation of $129K as Executive Chairman Principal Executive Officer at Capstone Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Salary | $50,000 |
|---|---|
| Other | $79,000 |
| Total | $129,000 |
Holliman received $79K in other compensation, accounting for 61% of the total pay in 2018.
Holliman also received $50K in salary.
Rankings
In 2018, John M. Holliman, III's compensation ranked 13,964th out of 14,244 executives tracked by ExecPay. In other words, Holliman earned more than 2.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,964 out of 14,244 | 2nd |
Division Manufacturing | 5,650 out of 5,758 | 2nd |
Major group Chemicals And Allied Products | 2,088 out of 2,119 | 2nd |
Industry group Drugs | 1,779 out of 1,808 | 2nd |
Industry Pharmaceutical Preparations | 1,360 out of 1,382 | 2nd |
Source: SEC filing on July 10, 2019.
Holliman's colleagues
We found one more compensation record of an executive who worked with John M. Holliman, III at Capstone Therapeutics in 2018.
2018
Les Taeger
Capstone Therapeutics